Merantix

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are left without adequate treatment options - and AI trained with complex disease data can solve this.

Briink is a developer of an artificial intelligence-powered platform that automates workflows for sustainable finance teams. The platform is specifically designed to assist asset managers, auditors, and corporations in streamlining their environmental, social, and governance (ESG) audit reporting processes. By utilizing advanced AI technology, Briink enables private equity firms and companies to efficiently manage taxonomy and comply with sustainable finance disclosure regulations. This automation facilitates informed investment decisions, enhances sustainability profiles, promotes transparency in ESG data, and helps mitigate the risks of greenwashing.

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are left without adequate treatment options - and AI trained with complex disease data can solve this.

Cambrium is focused on advancing material innovation by leveraging nature's protein building blocks. The company employs a combination of synthetic biology, machine learning, and lab automation to develop high-performance materials at scale. Cambrium specializes in creating micro-molecular and skin-identical collagen tailored for effective skincare formulations. Its innovative molecular design technology harnesses proteins with unique functionalities, allowing for the production of materials that are beneficial for both consumers and the environment. By aligning economic and environmental incentives, Cambrium aims to position biology as a key manufacturing technology for the future, addressing critical global challenges through the development of sustainable biomaterials.

Ovom Care is a healthcare company that utilizes artificial intelligence to offer personalized reproductive care services. It specializes in a range of fertility-related offerings, including fertility assessments, preservation, treatments, donor services, egg freezing, and in vitro fertilization (IVF). By providing these services, Ovom Care aims to support patients in making informed decisions regarding their fertility journeys.

Deltia is a developer of an AI-based process analytics platform aimed at enhancing productivity and quality in manual assembly processes. The platform employs computer vision technology to capture live video streams from cameras installed at individual assembly stations. These video streams are continuously analyzed by a flexible AI system that tracks workpiece movements, cycle times, and work step sequencing. By aggregating process data per article and production, Deltia provides valuable insights into process performance, allowing for comprehensive root-cause analysis through video snippets. Factory managers and process engineers can then leverage this data to define, implement, and measure targeted improvements, ultimately reducing errors and increasing operational flexibility on the assembly line.

Make your Legal work effortlessly efficient. Our LLM delivers unprecedented legal accuracy while removing the complexity of AI prompting and automation. Our AI workflows chain autonomous AI agents together to automate entire processes, just like in a law firm with specialised teams.

We build AI coaches that hyper-personalize mental health, starting with adult ADHD

Ovom Care is a healthcare company that utilizes artificial intelligence to offer personalized reproductive care services. It specializes in a range of fertility-related offerings, including fertility assessments, preservation, treatments, donor services, egg freezing, and in vitro fertilization (IVF). By providing these services, Ovom Care aims to support patients in making informed decisions regarding their fertility journeys.

Deltia is a developer of an AI-based process analytics platform aimed at enhancing productivity and quality in manual assembly processes. The platform employs computer vision technology to capture live video streams from cameras installed at individual assembly stations. These video streams are continuously analyzed by a flexible AI system that tracks workpiece movements, cycle times, and work step sequencing. By aggregating process data per article and production, Deltia provides valuable insights into process performance, allowing for comprehensive root-cause analysis through video snippets. Factory managers and process engineers can then leverage this data to define, implement, and measure targeted improvements, ultimately reducing errors and increasing operational flexibility on the assembly line.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Looks is a mobile application that enables users to customize outfits based on the occasion. Looks was founded in 2022 and was headquartered in Berlin, Germany.

Briink is a developer of an artificial intelligence-powered platform that automates workflows for sustainable finance teams. The platform is specifically designed to assist asset managers, auditors, and corporations in streamlining their environmental, social, and governance (ESG) audit reporting processes. By utilizing advanced AI technology, Briink enables private equity firms and companies to efficiently manage taxonomy and comply with sustainable finance disclosure regulations. This automation facilitates informed investment decisions, enhances sustainability profiles, promotes transparency in ESG data, and helps mitigate the risks of greenwashing.

Cambrium is focused on advancing material innovation by leveraging nature's protein building blocks. The company employs a combination of synthetic biology, machine learning, and lab automation to develop high-performance materials at scale. Cambrium specializes in creating micro-molecular and skin-identical collagen tailored for effective skincare formulations. Its innovative molecular design technology harnesses proteins with unique functionalities, allowing for the production of materials that are beneficial for both consumers and the environment. By aligning economic and environmental incentives, Cambrium aims to position biology as a key manufacturing technology for the future, addressing critical global challenges through the development of sustainable biomaterials.

Kausa is a developer of an analytics platform that specializes in providing ongoing data analysis to help businesses understand fluctuations in performance metrics. By testing various hypotheses, the platform delivers accurate explanations for changes in key performance indicators, empowering organizations to make informed decisions. Kausa's solutions cater to multiple industries, including media and entertainment, gaming, marketplaces, and e-commerce. The company offers contact options through email and a physical address for client inquiries.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Driven by digitalisation, ADAS and automated driving, automotive companies face one of their biggest challenges yet: the amount of data they are collecting is exploding. Most organisations use less than 5% of what they collect, are not able not commercialise their most valuable asset and instead waste millions on excess storage. To address this challenge, we have developed SiaSearch the category-leading search engine for petabyte-scale automotive data. Our technology automatically structures raw sensor data based on semantic attributes and keywords such as cut-ins, crowded intersections or dangerous overtaking. This metadata is powerful. By searching it, we can eliminate the time wasted on manual data crawling, automate the decision of what data to store and provide intelligent suggestions of what data would be most valuable to collect. With SiaSearch we are helping our customers to build smaller, higher density data sets. This does not just fast track their development but enables them to commercialise their data as an asset.

At Merantix Momentum, the experience doesn’t begin or end with their clients. It’s built from within by their people. They pride themselves on assembling the best machine learning engineers, team players, problem solvers, and creative thinkers.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.